Skip to main content

Articles By Jack Cush, MD

food healthy unhealthy beer alcohol salt

Anti-inflammatory Diet Control of Rheumatoid Arthritis

By Jack Cush, MD
09 April 2021

The TOMORROW study assessed the relationship between diet and disease activity in rheumatoid arthritis (RA) patients and has shown that RA patients are more likely to have higher inflammatory diets, but that a change to an anti-inflammatory diet resulted in lower disease activity scores.

Read Article
RheumNow Podcast square

RheumNow Podcast – Mistakes with Steroids

By Jack Cush, MD
08 April 2021

Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.

Read Article
HSPpalpp.JPG

Overview of New VEXAS Syndrome

By Jack Cush, MD
08 April 2021

Medscape offers up an informative overview of the newly described syndrome called VEXAS discovered by researchers at the National Institutes of Health.

Read Article
obesity.knee_.arthritis.jpg

GLP-1 Therapy in Knee Osteoarthritis

By Jack Cush, MD
08 April 2021

Knee osteoarthritis is best managed by weight loss, as the effects of most analgesic therapies have been marginal and debatable. The use of anti-diabetic glucagon-like peptide-1 therapies have demonstrated significant weight loss benefits; hence this trial evaluated the potential weight loss and pain relieving effects of liraglutide in obese patients with KOA.

Read Article
stop.smoking.jpg

Implementing Smoking Cessation Programs

By Jack Cush, MD
07 April 2021

Rheumatologists are keen to the effects of smoking (increased arthritis risk, worse outcomes, blunted DMARD responses, added cardiopulmonary risks), but often do not have the resources or plan to encourage or implement smoking cessation from the rheumatology clinic. A new study details the success of a rheumatology staff‐driven protocol, Quit Connect, to increase the rate of electronic referrals to free, state‐run tobacco quit lines.

Read Article
medical.problems.jpg

Rheumatology Care Derailed by COVID-19

By Jack Cush, MD
06 April 2021

A survey study from the  ArthritisPower PPRN or CreakyJoints database shows that during the COVID-19 pandemic patient care was substantially affected in unforeseen ways.

Read Article
COVID19.needles.Rx_.jpg

Reactogenicity Following mRNA COVID-19 Vaccines

By Jack Cush, MD
06 April 2021

JAMA has published the real-world reporting of mRNA vaccine side effects (reactogenicity) gathered from CDC V-safe Surveillance system and shows that local and systemic reactions were often mild and transient and most commonly seen during the first day following their second dose.

Read Article
cushknees1.jpg

Cost Efficacy of Knee Replacement in Obese Osteoarthritis

By Jack Cush, MD
05 April 2021

Total knee replacement (TKR) in obese patients with end-stage knee osteoarthritis appears to be a beneficial and cost-effective strategy for treating. The only potential limitation is a greater risk for adverse events in those with a body mass index (BMI) of 40 kg/m2 or greater.

Read Article
PSS.hands_.Raynauds.jpg (keep)

Rituximab in Systemic Sclerosis?

By Jack Cush, MD
05 April 2021

No drug is FDA approved to manage the skin or joint complaints of systemic sclerosis (SSc); a recent metanalysis suggests that rituximab may improve skin score and disease activity indices (DAS, mRSS) while stabilizing organ involvement in SSc patients.

Read Article
RheumNow Podcast square

RheumNow Podcast – Upadacitinib Wins in PsA (4.2.2021)

By Jack Cush, MD
02 April 2021

Dr Jack Cush reviews the news and Journal reports and takes "Back Talk" questions from viewers.

Read Article
×